[1]董孟佳,许尤琪,沈明勤.健脾活血方对SMMC-7721肝癌裸鼠抑瘤作用的研究[J].中国中医药信息杂志,2018,25(2):38-40.[doi:10.3969/j.issn.1005-5304.2018.02.009]
 DONG Meng-jia,XU You-qi,SHEN Ming-qin.Study of Anti-tumor Effect of Jianpi Huoxue Prescription on SMMC-7721 Hepatoma Mice[J].zhongguo zhongyiyao xinxi zazhi,2018,25(2):38-40.[doi:10.3969/j.issn.1005-5304.2018.02.009]
点击复制

健脾活血方对SMMC-7721肝癌裸鼠抑瘤作用的研究

参考文献/References:

[1] 方祯,李伟良,许尤琪.健脾活血中药复方联合TACE治疗肝癌的临床研究分析[J].中国卫生标准管理,2017,8(3):102-104.

[2] 王北婴,李仪奎.中药新药研制开发技术与方法[M].上海:上海科学技术出版社,2001:789.

[3] WEIDER N. Current pathologic methods for measuring intratumoral microvessel density with breast carcinoma and solid tumors[J]. Breast Cancer Res Treat,1995,36:169-180.

[4] 唐继贵,魏品康,张映城.消痰散结方对胃癌微血管密度及VEGF-A/ VEGFR-2的影响[J].世界中西医结合杂志,2015,10(3):346-349.

[5] POUYSSEGUR J, DAYAN F, MAZURE N M. Hypoxia signaling in cancer and approaches to enforce tumourregression[J]. Nature,2006,441437-443.

[6] 任洪军,张全安,赵伟.血管内皮生长因子及其受体与肝癌治疗的研究进展[J].肿瘤研究与临床,2008,20(1):70-72.

[7] 梁旭东.凋亡调控基因TRAIL、Caspase-3、Survivin在神经母细胞瘤中的检测及意义[D].郑州:郑州大学,2003.

[8] KANWAR J R, KAMALAPURAM S K, KANWARr R K, et al. Survivin signaling in clinical oncology:a multifaceted dragon[J]. Med Res Rev,2013,33(4):765-789.

[9] SHIN S, SUNG B J, CHO Y S, et al. Ananti apoptotic protein httm an Suivivin is a dirct inhibitor of Caspase-3 and Caspase-7[J]. Biochemistry,2001,40(4):1117-1123.

[10] 王维利,孟刚.Caspase-3与Survivin在肝细胞肝癌中的表达[J].安徽医科大学学报,2006,41(3):278-280.

相似文献/References:

[1]张定进,韦敏梅,王三虎,等.保肝利水汤联合腹腔化疗治疗肝癌并发腹水临床研究[J].中国中医药信息杂志,2010,17(3):77.
 [J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):77.
[2]范先基,杨子玉.王三虎治疗肝癌经验[J].中国中医药信息杂志,2009,16(8):86.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):86.
[3]张海,刘秀芳,赵增虎,等.疏肝健脾法防治肝癌患者肝动脉化疗栓塞后肝功能损伤临床研究[J].中国中医药信息杂志,2008,15(1):69.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):69.
[4]肖竺,田雪飞.单味中药抗肝癌实验研究进展[J].中国中医药信息杂志,2008,15(1):100.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):100.
[5]叶敏,矫健鹏,指导:魏品康.魏品康运用逍遥散验案举隅[J].中国中医药信息杂志,2011,18(9):101.[doi:10.3969/j.issn.1005-5304.2011.09.051]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(2):101.[doi:10.3969/j.issn.1005-5304.2011.09.051]
[6]玛依努尔·艾力,哈木拉提·吾甫尔.维吾尔药异常黑胆质成熟剂总黄酮逆转肝癌细胞耐药性的作用[J].中国中医药信息杂志,2007,14(9):31.
 Mayinur,Hamulati.The Reverse Effect of Uygur Medicine ASMq on the Drug Resistance Cells of Liver Cancer[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):31.
[7]董海涛,贺用和,卢雯平,等.艾迪注射液联合肝动脉介入治疗原发性肝癌33例临床观察[J].中国中医药信息杂志,2007,14(12):62.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):62.
[8]李继科,叶庆,高峰,等.陈定潜分阶段辨治肝癌肝移植术后复发验案[J].中国中医药信息杂志,2014,21(2):112.[doi:10.3969/j.issn.1005-5304.2014.02.039]
[9]张永琴,刘潇,韦艾凌.癌痛消药物血清对人肝癌细胞SMMC-7721和Bel-7404体外增殖及凋亡的影响[J].中国中医药信息杂志,2014,21(3):58.[doi:10.3969/j.issn.1005-5304.2014.03.017]
 ZHANG Yong-qin,LIU Xiao,WEI Ai-ling.Effect of Aitongxiao Granules Containing Serum on Proliferation and Apoptosis of SMMC-7721 and Bel-7404 Cells in Vitro[J].zhongguo zhongyiyao xinxi zazhi,2014,21(2):58.[doi:10.3969/j.issn.1005-5304.2014.03.017]
[10]刘华,李杳瑶,王理槐.扶正口服液防治伽玛刀治疗原发性肝癌毒副反应临床观察[J].中国中医药信息杂志,2013,20(10):65.[doi:10.3969/j.issn.1005-5304.2013.10.023]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(2):65.[doi:10.3969/j.issn.1005-5304.2013.10.023]

备注/Memo

基金项目:江苏省中医药局面上项目(YB2015051)

更新日期/Last Update:

2018-01-19